(Q67677128)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701755%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

editorial

0 references

title

Factors influencing response to interferon in chronic hepatitis B: implications for Asian and western populations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701755%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

Factors influencing response to interferon in chronic hepatitis B: Implications for Asian and western populations (English)

1 reference

https://api.crossref.org/works/10.1002/HEP.1840120626

2 November 2022

1 reference

1 reference

R. P. Perrillo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1701755

2 November 2022

language of work or name

English

0 references

publication date

1 December 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701755%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

16 September 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.1840120626

1 reference

https://api.crossref.org/works/10.1002/HEP.1840120626

https://onlinelibrary.wiley.com/doi/full/10.1002/hep.1840120626

2 November 2022

1 reference

https://api.crossref.org/works/10.1002/HEP.1840120626

2 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701755%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701755%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701755%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

page(s)

1433-1435

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701755%20AND%20SRC:MED&resulttype=core&format=json

Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B.

16 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120626

7 January 2021

A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120626

7 January 2021

Controlled clinical trial of acyclovir in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120626

7 January 2021

Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120626

7 January 2021

Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120626

7 January 2021

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120626

7 January 2021

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120626

7 January 2021

Mechanisms of action of interferons

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120626

7 January 2021

HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120626

7 January 2021

Changes in interferon receptors on peripheral blood mononuclear cells from patients with chronic hepatitis B being treated with interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120626

7 January 2021

Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine Arabinoside

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120626

7 January 2021

Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120626

7 January 2021

Multivariate survival analysis using Cox's regression model

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120626

7 January 2021

PLACEBO-CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE HBsAg-CARRIER CHILDREN

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120626

7 January 2021

LONG-TERM FOLLOW-UP IN A RANDOMISED CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE PATIENTS WITH CHRONIC HEPATITIS B INFECTION

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120626

7 January 2021

Transmission of HBsAg from mother to infant in four ethnic groups

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120626

7 January 2021

Prevalence of hepatitis B "e" antigen and its antibody in various HBsAg carrier populations

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120626

7 January 2021

Age-specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in taiwan: A comparison among asymptomatic carriers, Chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120626

7 January 2021

Chronic hepatitis in childhood: the spectrum of the disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120626

7 January 2021

Interferon antibodies may negate the antiviral effects of recombinant alpha-interferon treatment in patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120626

7 January 2021

Interferon antibodies in patients with chronic HBV infection treated with recombinant interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120626

7 January 2021

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120626

7 January 2021

Treatment of chronic hepatitis B with interferon: experience in Asian patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120626

7 January 2021

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701755%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

1 reference